BSX vs CUBE · P/E 20, rev $16.75B vs P/E 25, rev $1.07B
Boston Scientific Corp (BSX) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the BSX and CUBE stock pages for the full models.
Not investment advice.